Anti-diabetic effects of benfotiamine on an animal model of type 2 diabetes mellitus |
Chung, Kang Min
(Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University)
Kang, Wonyoung (Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University) Kim, Dong Geon (Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University) Hong, Hyun Ju (Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University) Lee, Youngjae (Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University) Han, Chang-Hoon (Department of Toxicology and Biochemistry, College of Veterinary Medicine, Jeju National University) |
1 | Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72, 248-254. DOI ScienceOn |
2 |
Ciaraldi TP, Nikoulina SE, Bandukwala RA, Carter L, Henry RR. Role of glycogen synthase kinase- |
3 | Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 2002, 51, 2903-2910. DOI ScienceOn |
4 | Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329, 977-986. DOI ScienceOn |
5 | Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000, 97, 12222-12226. DOI ScienceOn |
6 | Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res 2000, 87, 1123-1132. DOI ScienceOn |
7 | Gadau S, Emanueli C, Van Linthout S, Graiani G, Todaro M, Meloni M, Campesi I, Invernici G, Spillmann F, Ward K, Madeddu P. Benfotiamine accelerates the healing of ischemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia 2006, 49, 405-420. DOI ScienceOn |
8 | Gardner CD, Eguchi S, Reynolds CM, Eguchi K, Frank GD, Motley ED. Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp Biol Med 2003, 228, 836-842. DOI |
9 | Hays NP, Galassetti PR, Coker RH. Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther 2008, 118, 181-191. DOI ScienceOn |
10 | Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366, 1059-1062. DOI ScienceOn |
11 | Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992, 41, 1422-1428. DOI |
12 | Bitsch R, Wolf M, Moller J, Heuzeroth L, Gruneklee D. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamine derivative. Ann Nutr Metab 1991, 35, 292-296. DOI |
13 | Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK. Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 2005, 25, 1142-1147. DOI ScienceOn |
14 | Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ, Richardson AR, James JE. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 2009, 106, 17787-17792. DOI ScienceOn |
15 | Leng Y, Karlsson HKR, Zierath JR. Insulin signaling defects in type 2 diabetes. Rev Endocr Metab Disord 2004, 5, 111-117. DOI ScienceOn |
16 | Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404, 787-790. DOI ScienceOn |
17 | Nourooz-Zadeh J, Tajaddini-Surmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44, 1054-1058. DOI |
18 | Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia 1996, 39, 357-363. DOI ScienceOn |
19 | Schenk G, Duggleby RG, Nixon PF. Properties and functions of the thiamine diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol 1998, 30, 1297-1318. DOI ScienceOn |
20 | Park JL, Lee YS, Kim BH, Kang YH, Kim IJ, Kim YK, Son SM. Oxidative stress causes vascular insulin resistance in OLETF rat through increased IRS-1 degradation. J Korean Diabetes Assoc 2007, 31, 22-32. 과학기술학회마을 DOI ScienceOn |
21 | Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. Intracellular Glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 1990, 85, 522-529. DOI |
22 | UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352, 837-853. DOI ScienceOn |
23 | Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri H, Vlassara H, TSchoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006, 29, 2064-2071. DOI ScienceOn |
24 | Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994, 14, 1521-1528. DOI ScienceOn |
25 | Shao J, Yamashita H, Qiao L, Friedman JE. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J Endocrinol 2000, 167, 107-115. DOI ScienceOn |
26 | Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820. DOI ScienceOn |
27 | Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003, 9, 294 -299. DOI ScienceOn |
28 |
MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, Nagy A, Woodgett JR. Glycogen synthase kinase |
![]() |